Efficacy and safety of immunosuppressive therapy in myelin oligodendrocyte glycoprotein antibody–associated disease: a systematic review and meta-analysis

BACKGROUND: A considerable number of patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) will experience a relapse, but the effect of maintenance therapies on re-attack rates is currently unknown. OBJECTIVE: To investigate the efficacy and safety of immunosuppressiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Qi-Lun, Zhang, Yin-Xi, Cai, Meng-Ting, Zheng, Yang, Qiao, Song, Fang, Gao-Li, Shen, Chun-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591780/
https://www.ncbi.nlm.nih.gov/pubmed/34790259
http://dx.doi.org/10.1177/17562864211054157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591780/
https://www.ncbi.nlm.nih.gov/pubmed/34790259
http://dx.doi.org/10.1177/17562864211054157

Ejemplares similares